Yourgene Nx NIPT Workflow

Yourgene Nx NIPT Workflow

Home / Products / NIPT Solutions / Yourgene Nx NIPT Workflow

The Yourgene Nx NIPT Workflow is a non-invasive prenatal screening solution aimed at clinical laboratories to build their own laboratory developed test (LDT) to run their own NIPT service offering.

Customers can choose elements of our workflow from software, library preparation reagents and our game-changing fetal fraction enrichment technology and there is an option to customise the workflow to suit their own labs needs.

IONA Test

The Yourgene Nx NIPT Workflow is a lab developed test which utilises Next Generation Sequencing technology, to estimate the risk of a fetus having Trisomy 21, Trisomy 18, Trisomy 13, Rare Autosomal Aneuploidies (RAA), Sex Chromosome Aneuploidies (SCA) and the most clinically relevant microdeletions.

The workflow can deliver results from 2 to 3 days and is suitable for use from 10 gestational weeks for singleton or twin pregnancies.

Autosomal Aneuploidies

The Yourgene Nx NIPT Workflow estimates the risk of a fetus having Down’s syndrome (Trisomy 21), Edwards’ syndrome (Trisomy 18) and Patau’s syndrome (Trisomy 13). In addition, a genome-wide aneuploidy detection analysis on the remaining chromosomes can be carried out and reported.

Sex Chromosome Aneuploidies

The Yourgene Nx NIPT Workflow screens for the following sex chromosome aneuploidies:

45,X

Turner syndrome
seen in about 1 in 2,000 live female births

Read more
47,XXX

Triple X syndrome
seen in about 1 in 900-1,000 live female births

Read more
47,XXY

Klinefelter syndrome
seen in about 1 in 500-1,000 live male births

Read more
47,XYY

Jacobs syndrome
seen in about 1 in 1,000 live male births

Read more

Microdeletions

Microdeletion syndrome is caused by the absence of a small portion of genetic material in the chromosome. They can vary greatly in severity, with the symptoms of microdeletions ranging from minimal developmental delays to sever anomalies e.g. cardiac defects, neurological malformations etc. Upon request, the following clinically relevant microdeletions can be screened for:

  • DiGeorge syndrome (22q11.2 deletion)
  • 1p36 deletion syndrome
  • Prader-Willi syndrome (15q11.2-q13 deletion)
  • Angelman syndrome (15q11.2-q13 deletion)
  • Cri-du-Chat syndrome (5p15 deletion)
  • Wolf-Hirschhorn syndrome

Fetal Sex Determination

Upon request, the fetal sex can be determined with >99% accuracy.

Fetal Fraction

In order to minimise the risk of a false negative test result, the Yourgene Nx NIPT workflow estimates the fraction of circulating cell-free DNA which comes from the fetus (fetal fraction), relative to the cell-free DNA from the mother. The Yourgene Nx NIPT workflow incorporates clever bioinformatics software that is able to produce valid and accurate results in samples that have as little as 2.0% fetal fraction.

The Yourgene Nx NIPT Workflow is available in regions where a CE-marked IVD is not available.

Yourgene Health

How can we help?

If you have a question or would like to learn more about our products and services, we're here to help.